About Neuromuscular Diseases – Muscular Dystrophy Association

A look at causes, symptoms, and care options for neuromuscular diseases, and how we're leading the way to better treatments and cures.

At MDA, we take a big picture perspective across the full spectrum of neuromuscular diseases to uncover scientific and medical breakthroughs that accelerate treatments and cures. The power in our research approach is that we can often apply learnings from one disease to progress in others to bring urgently-needed answers to our families.

Read MDA News to stay up-to-date on issues that matter to the MDA community.

Biomarkers can provide crucial information for researchers conducting clinical trials.

James Ervasti, professor in the department of biochemistry, molecular biology & biophysics at the University of Minnesota in Minneapolis, is working to develop methods of identifying non-invasive biomarkers.

The FDA has approved Taro Pharmaceuticals Keveyis 50 mg tablets for primary hyperkalemic and hypokalemic periodic paralysis.

MDA helps you keep up on research news, health care information and helpful daily living strategies through magazines, print and online publications, educational speakers, seminars, videos and newsletters.

Our trained specialists are here to provide one-on-one support for every part of your journey. Send a message below or call us at 1-833-ASK-MDA1 (1-833-275-6321). If you live outside the U.S., we may be able to connect you to muscular dystrophy groups in your area, but MDA services are only available in the U.S.

Visit link:
About Neuromuscular Diseases - Muscular Dystrophy Association